Michael Matson

Stock Analyst at Needham

(2.72)
# 1,814
Out of 4,820 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return

Stocks Rated by Michael Matson

Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408$423
Current: $135.13
Upside: +213.03%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $7.28
Upside: +1,137.11%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $94.62
Upside: -43.99%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $72.90
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $235.88
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $101.91
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $37.25
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $365.70
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $15.14
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $58.02
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $60.74
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $2.69
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $1.22
Upside: -
Upgrades: Buy
Price Target: n/a
Current: $32.85
Upside: -